Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study.

Reingold J, Wanke C, Kotler D, Lewis C, Tracy R, Heymsfield S, Tien P, Bacchetti P, Scherzer R, Grunfeld C, Shlipak M.

J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):142-8. doi: 10.1097/QAI.0b013e3181685727.

2.

Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers.

Lee GA, Rao M, Mulligan K, Lo JC, Aweeka F, Schwarz JM, Schambelan M, Grunfeld C.

AIDS. 2007 Oct 18;21(16):2183-90.

3.

Class of antiretroviral drugs and the risk of myocardial infarction.

DAD Study Group, Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte Ad, El-Sadr W, Thiébaut R, De Wit S, Kirk O, Fontas E, Law MG, Phillips A, Lundgren JD.

N Engl J Med. 2007 Apr 26;356(17):1723-35.

4.

Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.

Kwong GP, Ghani AC, Rode RA, Bartley LM, Cowling BJ, da Silva B, Donnelly CA, van Sighem AI, Cameron DW, Danner SA, de Wolf F, Anderson RM.

AIDS. 2006 Oct 3;20(15):1941-50.

PMID:
16988515
6.

Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers.

Lee GA, Lo JC, Aweeka F, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C.

Clin Infect Dis. 2006 Sep 1;43(5):658-60. Epub 2006 Jul 26.

7.

Fat distribution in women with HIV infection.

Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM).

J Acquir Immune Defic Syndr. 2006 Aug 15;42(5):562-71.

8.

The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics.

Tien PC, Benson C, Zolopa AR, Sidney S, Osmond D, Grunfeld C.

Am J Epidemiol. 2006 May 1;163(9):860-9. Epub 2006 Mar 8.

9.

Overview of hemostatic factors involved in atherosclerotic cardiovascular disease.

Kannel WB.

Lipids. 2005 Dec;40(12):1215-20. Review.

PMID:
16477805
10.

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

Fibrinogen Studies Collaboration, Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, Pekkanen J, D'Agostino R, Kannel WB, Wilson PW, Tofler G, Arocha-Piñango CL, Rodriguez-Larralde A, Nagy E, Mijares M, Espinosa R, Rodriquez-Roa E, Ryder E, Diez-Ewald MP, Campos G, Fernandez V, Torres E, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen JT, Nyyssönen K, Tuomainen TP, Hedblad B, Lind P, Loewel H, Koenig W, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Després JP, Dagenais GR, Tunstall-Pedoe H, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Rudnicka A, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Kromhout D, Dickinson A, Ireland B, Juzwishin K, Kaptoge S, Lewington S, Memon A, Sarwar N, Walker M, Wheeler J, White I, Wood A.

JAMA. 2005 Oct 12;294(14):1799-809. Erratum in: JAMA. 2005 Dec 14;294(22):2848.

PMID:
16219884
11.

Fat distribution in men with HIV infection.

Bacchetti P, Gripshover B, Grunfeld C, Heymsfield S, McCreath H, Osmond D, Saag M, Scherzer R, Shlipak M, Tien P; Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM).

J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):121-31.

13.

Adipose tissue and atherothrombosis.

Alessi MC, Lijnen HR, Bastelica D, Juhan-Vague I.

Pathophysiol Haemost Thromb. 2003 Sep-2004 Dec;33(5-6):290-7. Review.

PMID:
15692231
14.

The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults.

Noor MA, Parker RA, O'Mara E, Grasela DM, Currie A, Hodder SL, Fiedorek FT, Haas DW.

AIDS. 2004 Nov 5;18(16):2137-44.

PMID:
15577646
15.

Body fat is the main predictor of fibrinogen levels in healthy non-obese men.

Bo M, Raspo S, Morra F, Cassader M, Isaia G, Poli L.

Metabolism. 2004 Aug;53(8):984-8.

16.

The metabolic effects of lopinavir/ritonavir in HIV-negative men.

Lee GA, Seneviratne T, Noor MA, Lo JC, Schwarz JM, Aweeka FT, Mulligan K, Schambelan M, Grunfeld C.

AIDS. 2004 Mar 5;18(4):641-9.

17.

Coronary heart disease in HIV-infected individuals.

Currier JS, Taylor A, Boyd F, Dezii CM, Kawabata H, Burtcel B, Maa JF, Hodder S.

J Acquir Immune Defic Syndr. 2003 Aug 1;33(4):506-12.

PMID:
12869840
18.

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

Klein D, Hurley LB, Quesenberry CP Jr, Sidney S.

J Acquir Immune Defic Syndr. 2002 Aug 15;30(5):471-7.

PMID:
12154337
19.

Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy.

Koppel K, Bratt G, Schulman S, Bylund H, Sandström E.

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):441-9.

PMID:
11981359
20.

Metabolic effects of indinavir in healthy HIV-seronegative men.

Noor MA, Lo JC, Mulligan K, Schwarz JM, Halvorsen RA, Schambelan M, Grunfeld C.

AIDS. 2001 May 4;15(7):F11-8.

Supplemental Content

Support Center